Diagnostic Testing for Urinary Tract Infections Using Molecular Methods: Uncertain Outcomes
-
By
-
Meghana Reddy
-
Christina Sze
-
Bonnie C. Prokesch
-
Philippe Zimmern
-
September 20, 2026
Clinical Scorecard: Diagnostic Testing for Urinary Tract Infections Using Molecular Methods: Uncertain Outcomes
At a Glance
| Category | Detail |
|---|
| Condition | Urinary Tract Infections (UTIs) |
| Key Mechanisms | Molecular diagnostic methods including PCR, multiplex PCR, next-generation sequencing, and loop-mediated isothermal amplification. |
| Target Population | Adults (≥ 18 years), including female participants. |
| Care Setting | Clinical diagnostics and treatment decision-making. |
Key Highlights
- Standard urine culture is the gold standard but has limitations in sensitivity and turnaround time.
- Molecular methods offer faster results and broader pathogen detection.
- PCR and NGS-based assays show higher detection rates but uncertain impact on clinical outcomes.
- Concerns exist regarding overdiagnosis and unnecessary antibiotic use with molecular diagnostics.
- The systematic review includes studies published from 2023 onward.
Guideline-Based Recommendations
Diagnosis
- Utilize molecular diagnostic methods for improved pathogen identification.
Management
- Consider empirical treatment while awaiting culture results, adjusting based on molecular diagnostics.
Monitoring & Follow-up
- Assess clinical outcomes and antibiotic selection based on molecular test results.
Risks
- Be aware of potential overdiagnosis and unnecessary antibiotic administration.
Patient & Prescribing Data
Adults with suspected urinary tract infections.
Molecular diagnostics may guide antibiotic selection but require careful interpretation to avoid overdiagnosis.
Clinical Best Practices
- Incorporate molecular diagnostics alongside traditional culture methods.
- Ensure appropriate patient selection for molecular testing to minimize false positives.
Related Resources & Content
